<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Raketten BIOTEC PHARMACON i startrampen.]]></title><description><![CDATA[<p dir="auto">Så kom meddelelsen om CE-mærkningen for selskabets sårsalve. Nu må vi så se om denne giver krudt nok til at min nytårsraket fra &quot;Millionærklubben&quot; d. 3. januar endelig letter fra jorden.</p>
<p dir="auto"><a href="http://arkiv.radio24syv.dk/video/9125951/00:27:18/million%C3%A6rklubben-02-01-2014" rel="nofollow ugc">http://arkiv.radio24syv.dk/video/9125951/00:27:18/millionærklubben-02-01-2014</a></p>
<p dir="auto">26/03-2014 19:58:54: (BIOTEC) MHRA has finalized the review of Woulgan<img
      src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/00ae.png?v=5ae451da0ae"
      class="not-responsive emoji emoji-android emoji--registered"
      style="height: 23px; width: auto; vertical-align: middle;"
      title="®"
      alt="®"
    /> Biogel<br />
Biotec BetaGlucans AS has today been informed that MHRA, the UK<br />
Medicines and Healthcare Products Regulatory Agency, has finalized the<br />
review of the medicinal part of the Woulgan<img
      src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/00ae.png?v=5ae451da0ae"
      class="not-responsive emoji emoji-android emoji--registered"
      style="height: 23px; width: auto; vertical-align: middle;"
      title="®"
      alt="®"
    /> Biogel dossier, and that<br />
their Decision Notification Report has been forwarded to Presafe. MHRA<br />
has been consulted as Competent Authority by the Notified Body, Presafe,<br />
to assess and approve the quality and role of SBG in Woulgan<img
      src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/00ae.png?v=5ae451da0ae"
      class="not-responsive emoji emoji-android emoji--registered"
      style="height: 23px; width: auto; vertical-align: middle;"
      title="®"
      alt="®"
    /> Biogel.<br />
The final issuance of a CE-certificate for Woulgan<img
      src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/00ae.png?v=5ae451da0ae"
      class="not-responsive emoji emoji-android emoji--registered"
      style="height: 23px; width: auto; vertical-align: middle;"
      title="®"
      alt="®"
    /> Biogel can now be<br />
finalized by the Notified Body. It is expected that Presafe will have<br />
the formal approval ready within soon.</p>
<p dir="auto">For more information, please contact:</p>
<p dir="auto">CEO Svein W. F. Lien, tel +47 922 89 323</p>
<p dir="auto">About Biotec BetaGlucans AS:</p>
<p dir="auto">Biotec BetaGlucans is a wholly owned subsidiary of Biotec Pharmacon ASA.<br />
Biotec BetaGlucans develops and manufactures novel immunomodulating<br />
products. The newly developed Woulgan<img
      src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/00ae.png?v=5ae451da0ae"
      class="not-responsive emoji emoji-android emoji--registered"
      style="height: 23px; width: auto; vertical-align: middle;"
      title="®"
      alt="®"
    /> Biogel, for use in wound healing,<br />
contains the company's proprietary substance SBG<img
      src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/00ae.png?v=5ae451da0ae"
      class="not-responsive emoji emoji-android emoji--registered"
      style="height: 23px; width: auto; vertical-align: middle;"
      title="®"
      alt="®"
    /> (soluble beta-glucan),<br />
which supports the wound healing process. When receiving CE-mark for the<br />
product the company is ready to start an evaluation study in regular<br />
clinical use together with the wound care world leader Smith &amp; Nephew.<br />
More information on <a href="http://www.biotec.no/beta-glucans/" rel="nofollow ugc">www.biotec.no/beta-glucans/</a></p>
<p dir="auto">Ekstern link: <a href="http://www.newsweb.no/index.jsp?messageId=349116" rel="nofollow ugc">http://www.newsweb.no/index.jsp?messageId=349116</a></p>
<p dir="auto">Med venlig hilsen</p>
<p dir="auto">Helge Larsen</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/437756/raketten-biotec-pharmacon-i-startrampen</link><generator>RSS for Node</generator><lastBuildDate>Sat, 25 Jul 2026 13:29:51 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/437756.rss" rel="self" type="application/rss+xml"/><pubDate>Wed, 26 Mar 2014 18:59:23 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Raketten BIOTEC PHARMACON i startrampen. on Fri, 04 Apr 2014 14:39:52 GMT]]></title><description><![CDATA[<p dir="auto">Tak for rosen. Blind høne finder jo også korn.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9447356</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9447356</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Fri, 04 Apr 2014 14:39:52 GMT</pubDate></item><item><title><![CDATA[Reply to Raketten BIOTEC PHARMACON i startrampen. on Fri, 04 Apr 2014 14:06:23 GMT]]></title><description><![CDATA[<p dir="auto">Det er super godt spottet Helge.<br />
Jeg tillod mig at købe et "frimærke" et par dage efter dit interview i Millionærklubben i januar.<br />
Og tillod mig endda at udvide positionen lidt med den gode meddelse i sidste uge:)</p>
<p dir="auto">Nu kom CE-mærkningen så til middag og aktien hopper også pænt.<br />
Den bliver helt sikkert spændende at følge i de næste par uger/måneder:)</p>
<p dir="auto">Tak for tippet.</p>
<p dir="auto">-HP</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9447344</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9447344</guid><dc:creator><![CDATA[ingenvenner]]></dc:creator><pubDate>Fri, 04 Apr 2014 14:06:23 GMT</pubDate></item><item><title><![CDATA[Reply to Raketten BIOTEC PHARMACON i startrampen. on Thu, 03 Apr 2014 07:51:24 GMT]]></title><description><![CDATA[<p dir="auto">BIOTEC - Sådan som jeg kender de norske aktieinvestorer, så vil de købe på meddelelsen om, at selskabet rent faktisk har modtaget CE-mærkningen med posten. Derfor reducerer jeg ikke i min beholdning pt. CE-mærkningen forventes at være fremme sidst i næste uge.</p>
<p dir="auto">Jeg fortæller om dette i udsendelsen i går efter 35 min.</p>
<p dir="auto"><a href="http://arkiv.radio24syv.dk/video/9592323/millionaerklubben-02-04-2014" rel="nofollow ugc">http://arkiv.radio24syv.dk/video/9592323/millionaerklubben-02-04-2014</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9447343</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9447343</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 03 Apr 2014 07:51:24 GMT</pubDate></item><item><title><![CDATA[Reply to Raketten BIOTEC PHARMACON i startrampen. on Mon, 31 Mar 2014 10:58:39 GMT]]></title><description><![CDATA[<p dir="auto"><a href="http://biotec.no/wp-content/uploads/2014/03/Carnegie-presentation.pdf" rel="nofollow ugc">http://biotec.no/wp-content/uploads/2014/03/Carnegie-presentation.pdf</a></p>
<p dir="auto">Helt ny og opdateret præsentation. Bemærk side 9 at alle 'claims' er godkendt, dvs. alle de positive udsagn om SBG er godkendt af MHRA</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9447346</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9447346</guid><dc:creator><![CDATA[Gjern]]></dc:creator><pubDate>Mon, 31 Mar 2014 10:58:39 GMT</pubDate></item><item><title><![CDATA[Reply to Raketten BIOTEC PHARMACON i startrampen. on Thu, 27 Mar 2014 17:27:44 GMT]]></title><description><![CDATA[<p dir="auto">Historien om BIOTEC og sårsalven</p>
<p dir="auto"><div class="card col-md-9 col-lg-6 position-relative link-preview p-0">

<div class="card-body">
<h5 class="card-title">
<a class="text-decoration-none" href="https://www.tu.no/industri/2012/09/29/denne-geleen-skal-lege-dine-sar">
Teknisk Ukeblad - Nyheter om teknologi og norske teknologibedrifter
</a>
</h5>
<p class="card-text line-clamp-3">Nyheter om teknologi  og norske teknologibedrifter. Vi dekker energi, maritim, bygg, industri, helse, elbiler, fly og samferdsel.</p>
</div>
<a href="https://www.tu.no/industri/2012/09/29/denne-geleen-skal-lege-dine-sar" class="card-footer text-body-secondary small d-flex gap-2 align-items-center lh-2">



<img src="https://www.tu.no/_neste/favicon.ico" alt="favicon" class="not-responsive overflow-hiddden" style="max-width: 21px; max-height: 21px;" onerror="this.remove()"/>





<p class="d-inline-block text-truncate mb-0">Tu.no <span class="text-secondary">(www.tu.no)</span></p>
</a>
</div></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9447341</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9447341</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 27 Mar 2014 17:27:44 GMT</pubDate></item><item><title><![CDATA[Reply to Raketten BIOTEC PHARMACON i startrampen. on Thu, 27 Mar 2014 14:14:01 GMT]]></title><description><![CDATA[<p dir="auto">BIOTEC - Massiv opjustering fra Carnegie</p>
<p dir="auto"><a href="http://www.hegnar.no/analyser/article760769.ece" rel="nofollow ugc">http://www.hegnar.no/analyser/article760769.ece</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/9447340</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9447340</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Thu, 27 Mar 2014 14:14:01 GMT</pubDate></item></channel></rss>